SECTION I. HEALTH APPRAISAL, RISK ASSESSMENT, AND SAFETY OF EXERCISE |
|
1 | (26) |
|
Benefits and Risks Associated with Exercise |
|
|
3 | (9) |
|
Public Health Perspective |
|
|
3 | (1) |
|
Benefits of Regular Physical Activity |
|
|
4 | (2) |
|
Risks Associated with Exercise Testing |
|
|
6 | (2) |
|
Risks Associated with Physical Activity |
|
|
8 | (4) |
|
Health Screening and Risk Stratification |
|
|
12 | (15) |
|
Health Screening for Physical Activity |
|
|
12 | (1) |
|
|
13 | (6) |
|
|
19 | (8) |
SECTION II. EXERCISE TESTING |
|
27 | (124) |
|
|
29 | (20) |
|
|
29 | (9) |
|
Contraindications to Exercise Testing |
|
|
38 | (3) |
|
|
41 | (6) |
|
|
47 | (2) |
|
|
49 | (37) |
|
Purposes of Fitness Testing |
|
|
50 | (1) |
|
Basic Principles and Guidelines |
|
|
51 | (2) |
|
|
53 | (10) |
|
Cardiorespiratory Endurance |
|
|
63 | (15) |
|
|
78 | (8) |
|
Clinical Exercise Testing |
|
|
86 | (24) |
|
Indications and Applications |
|
|
86 | (5) |
|
|
91 | (2) |
|
|
93 | (1) |
|
|
94 | (6) |
|
|
100 | (1) |
|
Indications for Exercise Test Termination |
|
|
100 | (1) |
|
Radionuclide Exercise Testing |
|
|
101 | (1) |
|
Non-Exercise Stress Tests or Pharmacological Tests |
|
|
102 | (1) |
|
Considerations for Pulmonary Patients |
|
|
102 | (4) |
|
|
106 | (4) |
|
Interpretation of Test Data |
|
|
110 | (41) |
|
Interpretation of Fitness Test Data |
|
|
110 | (2) |
|
Graded Exercise Testing as a Screening Tool for CAD |
|
|
112 | (12) |
|
Interpretation of Responses to Graded Exercise Testing |
|
|
124 | (6) |
|
Interpretation of Clinical Test Data |
|
|
130 | (10) |
|
Predictive Value of Exercise Testing |
|
|
140 | (6) |
|
Interpretation of Exercise Tests in Pulmonary Patients |
|
|
146 | (5) |
SECTION III. EXERCISE PRESCRIPTION |
|
151 | (90) |
|
General Principles of Exercise Prescription |
|
|
153 | (24) |
|
|
153 | (3) |
|
Cardiorespiratory Endurance |
|
|
156 | (10) |
|
Caloric Thresholds for Adaptation |
|
|
166 | (1) |
|
|
167 | (3) |
|
Musculoskeletal Flexibility |
|
|
170 | (2) |
|
|
172 | (3) |
|
|
175 | (2) |
|
Exercise Prescription for Cardiac Patients |
|
|
177 | (17) |
|
|
178 | (5) |
|
|
183 | (6) |
|
|
189 | (1) |
|
|
190 | (4) |
|
Exercise Prescription for Pulmonary Patients |
|
|
194 | (12) |
|
|
195 | (4) |
|
|
199 | (2) |
|
Alternative Modes of Exercise Training |
|
|
201 | (2) |
|
Program Design and Supervision |
|
|
203 | (3) |
|
Other Clinical Conditions Influencing Exercise Prescription |
|
|
206 | (14) |
|
|
206 | (3) |
|
Peripheral Vascular Disease |
|
|
209 | (4) |
|
|
213 | (3) |
|
|
216 | (4) |
|
Exercise Testing and Prescription for Children, the Elderly, and Pregnancy |
|
|
220 | (21) |
|
|
220 | (8) |
|
|
228 | (7) |
|
|
235 | (6) |
Appendix A. Common Medications |
|
241 | (12) |
Appendix B. Emergency Management |
|
253 | (10) |
Appendix C. ECG Interpretation and Related Diagnostic Information |
|
263 | (6) |
Appendix D. Metabolic Calculations |
|
269 | (19) |
Appendix E. Environmental Considerations |
|
288 | (9) |
Appendix F. American College of Sports Medicine Certifications |
|
297 | (58) |
Index |
|
355 | |